Physicians' Academy for Cardiovascular Education

Impacting progression and outcomes of DKD: Translating novel insights with GLP-1 ra to practice

Meeting report with presentation slides and video of a PACE-CME symposium held during ERA-EDTA 2019 in Budapest, Hungary on the role of GLP-1 ra in CKD

The science behind vascular and renal benefits of GLP-1 receptor agonists

10' education - June 12, 2019 - ERA-EDTA 2019 - Filip Krag Knop, MD
Prof. Knop describes the possible mechanisms of CV/CKD risk reduction by GLP-1 receptor activation.

Prof. Knop describes the possible mechanisms of CV/CKD risk reduction by GLP-1 receptor activation.

Clinical outcomes of GLP-1RA in kidney disease: Current evidence and ongoing trials

10' education - July 12, 2019 - ERA-EDTA 2019 - Frederik Persson, MD
Frederik Persson shows evidence of renoprotective effects with GLP-1RA treatment, by discussing various small clinical trials as well as CVOTs with GLP-1RAs.

Frederik Persson shows evidence of renoprotective effects with GLP-1RA treatment, by discussing various small clinical trials as well as CVOTs with GLP-1RAs.

Importance of protection and prevention in diabetic cardiorenal disease

10' education - July 12, 2019 - ERA-EDTA 2019 - Prof. John Deanfield, MD
We have entered a new era for treatment of cardiorenal disease in diabetes. Prof. John Deanfield discusses evidence on the need for early management and alteration of upstream factors that affect renal and cardiac function in diabetic patients.

We have entered a new era for treatment of cardiorenal disease in diabetes. Prof. John Deanfield discusses evidence on the need for early management and alteration of upstream factors that affect renal and cardiac function in diabetic patients.

Slides: Clinical outcomes of GLP-1 RA in kidney disease: Current evidence and ongoing trials

Slides (presentation) - July 3, 2019 - Frederik Persson, MD – Copenhagen, Denmark - CME symposium held during ERA EDTA 2019
This lecture by dr. Frederik Persson was part of a CME-accredited symposium

Slides as educational service to PACE members and meeting participants

Slides: The science behind vascular and renal benefits of GLP-1 receptor agonists

Slides (presentation) - July 3, 2019 - Filip Krag Knop, MD – Copenhagen, Denmark - CME symposium held during ERA EDTA 2019
This lecture by prof. Filip Krag Knop was part of a CME-accredited symposium

Slides as educational service to PACE members and meeting participants

Slides: Importance of protection and prevention in cardiorenal disease

Slides (presentation) - July 3, 2019 - John Deanfield, MD – London, United Kingdom - CME symposium held during ERA EDTA 2019
This lecture by prof. John Deanfield was part of a CME-accredited symposium

Slides as educational service to PACE members and meeting participants

Impacting progression and outcomes of DKD: Translating novel insights with GLP-1 ra to practice

10' Education

The science behind vascular and renal benefits of GLP-1 receptor agonists

10' education - June 12, 2019 - ERA-EDTA 2019 - Filip Krag Knop, MD

Clinical outcomes of GLP-1RA in kidney disease: Current evidence and ongoing trials

10' education - July 12, 2019 - ERA-EDTA 2019 - Frederik Persson, MD

Importance of protection and prevention in diabetic cardiorenal disease

10' education - July 12, 2019 - ERA-EDTA 2019 - Prof. John Deanfield, MD

Presentation Slides

Slides: Clinical outcomes of GLP-1 RA in kidney disease: Current evidence and ongoing trials

Slides (presentation) - July 3, 2019 - Frederik Persson, MD – Copenhagen, Denmark - CME symposium held during ERA EDTA 2019

Slides: The science behind vascular and renal benefits of GLP-1 receptor agonists

Slides (presentation) - July 3, 2019 - Filip Krag Knop, MD – Copenhagen, Denmark - CME symposium held during ERA EDTA 2019

Slides: Importance of protection and prevention in cardiorenal disease

Slides (presentation) - July 3, 2019 - John Deanfield, MD – London, United Kingdom - CME symposium held during ERA EDTA 2019